Picture of AxoGen logo

AXGN — AxoGen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

AxoGen Inc reports results for the quarter ended in March - Earnings Summary

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 15
cents per share.
    * Revenue fell 0.1% to $31.01 million from a year ago; 
analysts
expected $30.79 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 27
cents​.
    * The mean earnings estimate of analysts had fallen by
about 43.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * AxoGen Inc shares had risen by 4.0% this quarter and
lost 11.8%
so far this year.
    * The company reported a quarterly loss of $11.48 million.
    * Wall Street's median 12-month price target for AxoGen Inc
is
$20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 09:04 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on AxoGen

See all news